TG Therapeutics Inc (TGTX)

Financial leverage ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total assets	US$ in thousands	577,690	586,014	401,207	373,323	329,587	331,067	220,854	197,358	193,572	217,891	251,666	303,028	379,629	409,687	481,400	548,699	625,642	273,856	294,621	101,849
Total stockholders’ equity	US$ in thousands	222,364	192,157	177,568	160,109	160,502	164,769	40,453	27,433	58,587	100,481	129,035	170,386	237,153	311,517	383,130	445,285	519,350	170,658	194,227	-1,353
Financial leverage ratio		2.60	3.05	2.26	2.33	2.05	2.01	5.46	7.19	3.30	2.17	1.95	1.78	1.60	1.32	1.26	1.23	1.20	1.60	1.52	—

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $577,690K ÷ $222,364K
= 2.60

The financial leverage ratio represents the extent to which a company relies on debt to finance its operations and growth. An increasing financial leverage ratio indicates a higher level of debt relative to equity in the company's capital structure.

Based on the data provided for TG Therapeutics Inc, we see fluctuations in the financial leverage ratio over the quarterly periods analyzed. The ratio was not available for March 31, 2020. From June 30, 2020, to September 30, 2021, the ratio progressively increased from 1.52 to 1.32, indicating a rising reliance on debt during this period.

The financial leverage ratio then spiked significantly in the next quarter, reaching 3.30 by December 31, 2022. This sharp increase suggests a substantial shift towards higher debt levels in the company's capital structure. The ratio continued to fluctuate in the subsequent quarters, showcasing varying levels of debt dependency.

As of December 31, 2024, the financial leverage ratio stood at 2.60. Although it decreased from its peak in March 31, 2023, the ratio remains relatively high compared to the earlier periods. It indicates that TG Therapeutics Inc is still maintaining a significant portion of debt in its financial structure in relation to equity.

Overall, the trend in TG Therapeutics Inc's financial leverage ratio suggests fluctuations in its debt-to-equity position, with periods of higher debt reliance followed by adjustments. This ratio provides insights into the company's financing decisions and risk exposure related to its debt levels.